Table 1

Characteristics of included trials

CharacteristicNot registeredRegisteredTotal
(N=23)(N=229)(N=252)
N, %N, %N, %
Type of award
Programme3 (13.0)18 (7.9)21 (8.4)
Project6 (26.1)138 (60.3)144 (57.2)
Feasibility4 (17.4)25 (10.9)29 (11.6)
Career development awards*5 (21.7)23 (10.0)28 (10.8)
IIOF-5 (2.2)5 (2.0)
DHB Partnership Programme-16 (7.0)16 (6.4)
Explorer-1 (0.4)1 (0.4)
Missing5 (21.7)3 (1.3)8 (3.2)
Type of trial
2-arm RCT9 (39.1)170 (74.6)179 (71.6)
Multiarm RCT5 (21.7)21 (9.2)26 (11.4)
Factorial RCT-7 (3.1)7 (2.8)
Cluster RCT7 (30.4)18 (7.9)25 (10.0)
Cross-over RCT1 (4.3)6 (2.6)7 (2.4)
No of centres
Single centre15 (65.2)120 (52.4)135 (53.6)
Multicentre4 (17.4)96 (41.9)100 (39.7)
Missing4 (17.4)13 (5.7)17 (6.7)
Type of intervention
Drug2 (8.7)89 (38.9)91 (36.0)
Device2 (8.7)34 (14.8)36 (14.4)
Procedure/behavioural17 (73.9)101 (44.1)118 (46.8)
Food2 (8.7)2 (0.9)4 (1.6)
Other-3 (1.3)3 (1.2)
Type of participant recruited
Adult16 (69.6)179 (78.2)194 (77.6)
Child†6 (26.1)44 (19.2)50 (20.0)
Adult or child-6 (2.6)6 (2.4)
Missing1 (4.3)-1 (0.4)
Sample size
Target sample size‡96 (31–300)308 (104–918)284 (100–800)
Actual sample size‡80 (34–276)251 (95–712)225 (89–666)
Trials register§
ANZCTR-192 (83.)192 (76.1)
ClinicalTrials.gov-31 (13.5)31 (13.5)
ISRCTN-6 (2.6)6 (2.4)
  • *Includes both junior and senior career awards.

  • †Includes adolescents.

  • ‡Median and IQR.

  • §Missing information.

  • ANZCTR, Australia New Zealand Clinical Trials Register; DHB, District Health Board; IIOF, International Investment Opportunities Fund; ISRCTN, International Standard Randomised Controlled Trial Number; RCT, randomised controlled trial.